3 results
Approved WMOCompleted
Primary ObjectiveTo evaluate the efficacy and safety/tolerability of UK-432,097 DPI in adults with moderate to severe COPD (GOLD stage II/III).
Approved WMOCompleted
The primary objective is to determine the efficacy of pain control with this type of Peripheral Subcutaneous Field Stimulation (PSFS) at three months and 12 months. The secondary objectives determined at both 3 and 12 months are the assessment of…
Approved WMOCompleted
The primary objective of this study is:• To evaluate whether simtuzumab (formally referred to as GS-6624) is effective at preventing the progression of liver fibrosis in subjects with PSC.The secondary objectives of this study include the following…